Patrick C. Mahon

3.6k citations

10 papers · 3.0k indexed · 2 hit papers · h-index 10

Impact in

Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 5%
- Mitochondrial Function and Pathology
- RNA modifications and cancer
- Angiogenesis and VEGF in Cancer
- Epigenetics and DNA Methylation
- Metabolism, Diabetes, and Cancer

Papers in

Cancer Research 7
- Cancer, Hypoxia, and Metabolism 4
- Cancer Genomics and Diagnostics 2
Oncology 7
- Cancer-related Molecular Pathways 3
- Pancreatic and Hepatic Oncology Research 2
- Drug Transport and Resistance Mechanisms 2

Co-authors: Gregg L. Semenza Kiichi Hirota Erik Laughner Panthea Taghavi Kelly A. Chiles Nicholas R. Lemoine Patrick Baril Tatjana Crnogorac‐Jurcevic
Journals: Genes & Development (1 paper)British Journal of Cancer (1 paper)Clinical Cancer Research (1 paper)FEBS Letters (1 paper)Oncotarget (1 paper)
Partner nations: United Kingdom United States Japan

In The Last Decade

Patrick C. Mahon

10 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression 2001 · 1.0k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2001 Molecular and Cellular Biology
2001 Genes & Development

Peers

Countries citing papers authored by Patrick C. Mahon

Since Specialization

Citations

This map shows the geographic impact of Patrick C. Mahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick C. Mahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick C. Mahon more than expected).

Fields of papers citing papers by Patrick C. Mahon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick C. Mahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick C. Mahon. The network helps show where Patrick C. Mahon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Patrick C. Mahon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick C. Mahon Line = papers co-authored together Patrick C. Mahon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work
1	VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells Oncotarget ·Jonathan D. Moore, Anna D. Staniszewska, نجوان القبانی, Kira Busch, Ben Davis, Alan Surgenor, Lisa Baker, Natalia Matassova, James B. Murray, Alba T. Macias, Paul A. Brough, Mike Wood, Patrick C. Mahon	2014	51
2	Identification of genetic alterations in pancreatic cancer by the combined use of tissue microdissection and array-based comparative genomic hybridisation British Journal of Cancer ·Takeshi Harada, Patrick Baril, Rathi Gangeswaran, Gavin Kelly, Claude Chelala, Vipul Bhakta, Lei Liu, Patrick C. Mahon, Nicholas R. Lemoine	2007	36
3	S100A4 Contributes to the Suppression of BNIP3 Expression, Chemoresistance, and Inhibition of Apoptosis in Pancreatic Cancer Cancer Research ·Patrick C. Mahon, Patrick Baril, Vipul Bhakta, Claude Chelala, Lei Liu, Tomohiko Harada, Nicholas R. Lemoine	2007	93
4	Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the β4 integrin and the PI3k pathway Oncogene ·Patrick Baril, Rathi Gangeswaran, Patrick C. Mahon, Lei Liu, Hemant M. Kocher, Tomochika Harada, Min Zhu, Holger Kalthoff, Tatjana Crnogorac‐Jurcevic, Nicholas R. Lemoine	2006	245
5	OS-9 Interacts with Hypoxia-Inducible Factor 1α and Prolyl Hydroxylases to Promote Oxygen-Dependent Degradation of HIF-1α Molecular Cell ·Jin Hyen Baek, Patrick C. Mahon, Jane C Oh, Brian Kelly, Balaji Krishnamachary, Myra Lewontin, Denise A. Chan, Amato J. Giaccia, Gregg L. Semenza	2005	187
6	Intrinsic Chemoresistance to Gemcitabine Is Associated with Decreased Expression of BNIP3 in Pancreatic Cancer Clinical Cancer Research ·Masanori Akada, Tatjana Crnogorac‐Jurcevic, Victoria Kim, Patrick C. Mahon, Rita Lopes, Makoto Sunamura, Seiki Matsuno, Nicholas R. Lemoine	2005	125
7	FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity Genes & Development ·Patrick C. Mahon, Kiichi Hirota, Gregg L. Semenza Hit paper breakdown →	2001	1144
8	HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression Molecular and Cellular Biology ·Erik Laughner, Panthea Taghavi, Kelly A. Chiles, Patrick C. Mahon, Gregg L. Semenza Hit paper breakdown →	2001	1037
9	The 3′ untranslated region plays a role in the targeting of metallothionein-I mRNA to the perinuclear cytoplasm and cytoskeletal-bound polysomes Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Patrick C. Mahon, Kris Partridge, John Beattie, L. Anne Glover, John E. Hesketh	1997	29
10	Localisation of metallothionein isoform mRNAs in rat hepatoma (H4) cells FEBS Letters ·Patrick C. Mahon, John Beattie, L. Anne Glover, John E. Hesketh	1995	14

About Patrick C. Mahon

Patrick C. Mahon is a scholar working on Cancer Research, Oncology, Hematology, Nutrition and Dietetics and Molecular Biology, having authored 10 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer-related Molecular Pathways (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Trace Elements in Health (2 papers), Cancer Genomics and Diagnostics (2 papers), Iron Metabolism and Disorders (2 papers) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Cancer Research (2.0k citations), Molecular Biology (1.9k citations), Biochemistry (159 citations), Oncology (595 citations) and Genetics (418 citations). Patrick C. Mahon has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Gregg L. Semenza, Kiichi Hirota, Erik Laughner, Panthea Taghavi, Kelly A. Chiles, Nicholas R. Lemoine, Patrick Baril, Tatjana Crnogorac‐Jurcevic, Rathi Gangeswaran and Hemant M. Kocher. Their work appears in journals such as Genes & Development, British Journal of Cancer, Clinical Cancer Research, FEBS Letters and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact